1.	A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women Phase: Phase I Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening Status: Active Age: 25 to 80 Sponsor: Other Protocol IDs: P50CA83636-01, 6973, NCT01121640
2.	Specimen and Data Study for Ovarian Cancer Early Detection and Prevention Phase: No phase specified Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095
3.	Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer Phase: No phase specified Type: Screening Status: Active Age: 30 and over Sponsor: NCI, Other Protocol IDs: CDR0000069397, MGH-000084, NCT00039559
4.	Cancer Screening and Prevention Program for High Risk Women Phase: No phase specified Type: Health services research, Screening Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 00-60, NYU H#9541, NCT00849199
5.	Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Screening Status: Active Age: 21 and over Sponsor: NCI Protocol IDs: WIHRI-09-0030, 09-0030, NCT00986206
6.	Early Detection of Cancers in Low Resource Countries Phase: No phase specified Type: Diagnostic, Screening Status: Approved-not yet active Age: 30 to 64 Sponsor: Other Protocol IDs: WCF-2011-BRA-IND-CAM, NCT01178736
7.	Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 30 and over Sponsor: Other Protocol IDs: IR 4707, CRC 08108, NCT01292733